Guardant Health Inc (GH)
22.88
+0.15
(+0.66%)
USD |
NASDAQ |
Sep 27, 16:00
22.91
+0.03
(+0.13%)
After-Hours: 20:00
Guardant Health SG&A Expense (Annual): 451.03M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 451.03M |
| December 31, 2022 | 463.78M |
| December 31, 2021 | 398.52M |
| December 31, 2020 | 299.28M |
| Date | Value |
|---|---|
| December 31, 2019 | 139.73M |
| December 31, 2018 | 89.66M |
| December 31, 2017 | 69.27M |
| December 31, 2016 | 36.11M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
139.73M
Minimum
2019
463.78M
Maximum
2022
350.47M
Average
398.52M
Median
2021
SG&A Expense (Annual) Benchmarks
| Exact Sciences Corp | 1.620B |
| Illumina Inc | 1.612B |
| Delcath Systems Inc | 22.11M |
| CytoSorbents Corp | 37.87M |
| Progyny Inc | 176.62M |